Ribomic

Developer of aptamer-based therapeutics for the treatment of multiple diseases

placeChiba, Chiba, Japan calendar_todayFounded 2003 groups25 employees language ribomic.com

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital686%
Private equity114%
Coming soon